Case Study / Flagship Pioneering 83% of reference reports are completed in under 2 days. Saved by TA team by using Crosschq instead of manual reference check process. Of references opt-in to talent pool for other open at Flagship Pioneering. “Crosschq has fit seamlessly into our current workflow and we are getting some great data that informs onboarding a new hire as well.” Emily Gransky Director, Talent Acquisition & Operations at Flagship Pioneering Save Time, Hire Better
A
Customer Case Study
<48 Hours
450+ Hours
35%
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).